|
Dr. Veillette received his M.D. in 1982 from Laval University. He was a professor at the McGill Cancer Center at McGill University and is currently professor in the Department of Molecular Oncology at the Clinical Research Institute of Montreal. In 1995 he was elected a member of the American Society for Clinical Investigation. He has received the André Dupont Young Investigator Award, the Merck Frosst Prize, and the Marcel-Piché Award. In 2002 he was named Canadian Research Chair in Signalling in the Immune System; in 2007 he received the Léo-Pariseau Prize, a Quebecois prize awarded by the Francophone Association for Knowledge and sponsored by Merk Frosst; in 2008 he was elected member of the Royal Society of Canada; and in 2009 he received the Hardy-Cinader Award from Canadian Society of Immunology and was elected member of Association of American Physicians.
RESEARCH ABSTRACT SUMMARY:
André Veillette is interested in elucidating the molecular mechanisms that control the activation and differentiation of immune cells, in particular T cells and natural killer cells. He is using a combination of biochemical approaches and mouse genetics to understand how immune cells control health and disease.
View Research Abstract
Photo: Nuno Botelho
|
